AltruBio

Drug Discovery · San Francisco, CA · Founded 2000 · Privately Held (backing)

Developer of first-in-class immune-modulators to target diseases of the immune system. AltruBio is based in San Francisco, CA and was founded in 2000. It has raised $337 million across 1 recorded round; the latest was a $225 million Series B in May 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$336.6M
Last round
Later Stage VC (Series B)
May 2024
No prints on record

No secondary trades in AltruBio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AltruBio with a free account
  • ·Watch AltruBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Where AltruBio prices come from

Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of AltruBio stock.